Ninety One UK Ltd Has $22.69 Million Stock Position in Agilent Technologies, Inc. (NYSE:A)

Ninety One UK Ltd reduced its position in Agilent Technologies, Inc. (NYSE:A) by 8.3% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 163,219 shares of the medical research company’s stock after selling 14,794 shares during the period. Ninety One UK Ltd owned about 0.06% of Agilent Technologies worth $22,692,000 as of its most recent filing with the SEC.

Other hedge funds have also bought and sold shares of the company. Kepos Capital LP boosted its stake in Agilent Technologies by 3.5% in the third quarter. Kepos Capital LP now owns 2,775 shares of the medical research company’s stock valued at $310,000 after acquiring an additional 93 shares during the last quarter. Ancora Advisors LLC increased its stake in shares of Agilent Technologies by 41.1% in the 1st quarter. Ancora Advisors LLC now owns 326 shares of the medical research company’s stock worth $45,000 after acquiring an additional 95 shares in the last quarter. Rosenberg Matthew Hamilton increased its stake in Agilent Technologies by 51.1% during the 4th quarter. Rosenberg Matthew Hamilton now owns 284 shares of the medical research company’s stock valued at $39,000 after purchasing an additional 96 shares in the last quarter. Ronald Blue Trust Inc. increased its stake in Agilent Technologies by 8.1% during the 3rd quarter. Ronald Blue Trust Inc. now owns 1,336 shares of the medical research company’s stock valued at $161,000 after purchasing an additional 100 shares in the last quarter. Finally, Invesco LLC grew its stake in shares of Agilent Technologies by 0.7% in the third quarter. Invesco LLC now owns 15,471 shares of the medical research company’s stock worth $1,730,000 after acquiring an additional 101 shares during the period.

Analyst Ratings Changes

A number of analysts have recently commented on A shares. Barclays lifted their price target on shares of Agilent Technologies from $125.00 to $135.00 and gave the stock an “underweight” rating in a research note on Wednesday, April 10th. UBS Group raised their price objective on shares of Agilent Technologies from $130.00 to $155.00 and gave the stock a “neutral” rating in a report on Wednesday, February 28th. Evercore ISI raised their price objective on shares of Agilent Technologies from $132.00 to $145.00 and gave the stock an “in-line” rating in a report on Thursday, April 4th. Stifel Nicolaus raised shares of Agilent Technologies from a “hold” rating to a “buy” rating and raised their price objective for the stock from $145.00 to $163.00 in a report on Friday, April 5th. Finally, Citigroup raised their price objective on shares of Agilent Technologies from $130.00 to $145.00 and gave the stock a “neutral” rating in a report on Wednesday, February 28th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $141.29.

Insider Buying and Selling at Agilent Technologies

In other Agilent Technologies news, VP Rodney Gonsalves sold 4,828 shares of the business’s stock in a transaction on Thursday, March 7th. The shares were sold at an average price of $149.00, for a total transaction of $719,372.00. Following the transaction, the vice president now owns 21,329 shares in the company, valued at $3,178,021. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other Agilent Technologies news, SVP Philip Binns sold 2,827 shares of the business’s stock in a transaction on Monday, March 25th. The shares were sold at an average price of $147.54, for a total transaction of $417,095.58. Following the transaction, the senior vice president now owns 9,997 shares in the company, valued at $1,474,957.38. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Rodney Gonsalves sold 4,828 shares of the business’s stock in a transaction on Thursday, March 7th. The shares were sold at an average price of $149.00, for a total transaction of $719,372.00. Following the sale, the vice president now directly owns 21,329 shares of the company’s stock, valued at $3,178,021. The disclosure for this sale can be found here. Insiders have sold 61,610 shares of company stock worth $9,220,333 over the last quarter.

Agilent Technologies Trading Down 1.6 %

Shares of A opened at $132.44 on Friday. The company’s fifty day moving average is $141.19 and its 200 day moving average is $129.50. Agilent Technologies, Inc. has a fifty-two week low of $96.80 and a fifty-two week high of $151.58. The stock has a market capitalization of $38.81 billion, a PE ratio of 31.53, a P/E/G ratio of 4.07 and a beta of 1.11. The company has a debt-to-equity ratio of 0.41, a quick ratio of 2.04 and a current ratio of 2.68.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Tuesday, February 27th. The medical research company reported $1.29 earnings per share for the quarter, topping the consensus estimate of $1.22 by $0.07. Agilent Technologies had a net margin of 18.35% and a return on equity of 27.09%. The company had revenue of $1.66 billion for the quarter, compared to analysts’ expectations of $1.59 billion. During the same quarter in the previous year, the business posted $1.37 earnings per share. Agilent Technologies’s quarterly revenue was down 5.5% on a year-over-year basis. Sell-side analysts expect that Agilent Technologies, Inc. will post 5.51 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 24th. Investors of record on Tuesday, April 2nd will be given a $0.236 dividend. This represents a $0.94 annualized dividend and a yield of 0.71%. The ex-dividend date is Monday, April 1st. Agilent Technologies’s dividend payout ratio is presently 22.38%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.